Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors

NCT05836324 is registered in ClinicalTrials.gov with Incyte Corporation as lead sponsor.

NCT NCT05836324
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05836324 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1, Open-Label, Multicenter Study of INCA33890 in Participants With Advanced or Metastatic Solid Tumors
Lead sponsor
Incyte Corporation
Phase
Phase 1
Overall status
Recruiting
Start date
July 24, 2023
Completion date
May 3, 2029
Enrollment
570 (estimated)
Sites
39

Conditions

As the registry lists them; a condition with its own page is linked.

advanced solid tumors, metastatic solid tumors, solid tumors